Grants and Contributions:
Grant or Award spanning more than one fiscal year (2017-2018 to 2018-2019).
A novel mucoadhesive micelle has been developed which can be formulated with a therapeutic for drug delivery to the eye. Testing of micelles synthesized using RAFT polymerization containing cyclosporine A has demonstrated the efficacy of the formulation. Details can be found at: http://www.2020optimeyes.ca/Documents/I2I.pdf The proposed project will focus on creating the micelles using the more industrially-friendly and scalable free radical polymerization method, and exploring the potential manufacturing strategies of these drug loaded compounds. This will allow industrial partners to assess the licensing potential of these materials using a synthesis method consistent with their standard practices.